Iran executes scientist

RESEARCH
Cancer drug fails
A promising lung-cancer drug failed in a key clinical trial, sending stock in the drug's developer, BristolMyers Squibb, tumbling by 17% on 5 August. The drug, called Opdivo (nivolumab) , is one of a suite of new cancer therapies that release immune responses against tumours by blocking a protein called PD-1. Opdivo has been shown to benefit some people with advanced cancers, including lung cancer. But Bristol-Myers Squibb, which is based in New York City, announced last week that Opdivo had failed as a front-line therapy for lung cancer. Stock in a competing firm, Merck of Kenilworth, New Jersey, rose 10% after the news. 
Mosquito trial
Goodnight Yutu
China's moon rover Yutu, or Jade Rabbit, was officially declared dead by state officials on 3 August. It arrived on the Moon in December 2013, and was intended to carry out a three-month exploration of the lunar surface, but it survived for more than two years before going dark for the last time. The six-wheeled, solarpowered rover was struck by mechanical difficulties in early 2014, but had already used its penetrating radar to probe the structure of the lunar soil to a depth of more than 100 metres, and sent back data and high-resolution images to Earth. The mission made China the third country Erdoğan and his son -which Erdoğan said were fabricated -were not manipulated. effort to control diseases they transmit, including dengue and Zika viruses. Local residents will vote in a non-binding referendum, currently slated for November, before the board decides whether to go ahead with the trial. 
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